Disease Markers

Disease Markers / Published Special Issues / Special Issue

Mass Spectrometry and Biomarker Development

Status
Published
Guest Editors
Karin D. Rodland

Mass Spectrometry and Biomarker Development

Download Special Issue

Articles

  • Special Issue
  • - Volume 20
  • - Article ID 945073

Update on Diabetes Mellitus

Murray Korc
  • Special Issue
  • - Volume 20
  • - Article ID 754640

A Rational Approach for Discovering and Validating Cancer Markers in Very Small Samples Using Mass Spectrometry and ELISA Microarrays

Richard C. Zangar | Susan M. Varnum | ... | Richard D. Smith
  • Special Issue
  • - Volume 20
  • - Article ID 965261

Heart Disease, Clinical Proteomics and Mass Spectrometry

Brian A. Stanley | Rebekah L. Gundry | ... | Jennifer E. Van Eyk
  • Special Issue
  • - Volume 20
  • - Article ID 569810

Mass Spectrometry and Biomarker Development

Karin D. Rodland
  • Special Issue
  • - Volume 20
  • - Article ID 829450

Proteomics Approaches to Identify Tumor Antigen Directed Autoantibodies as Cancer Biomarkers

Yuji Imafuku | Gilbert S. Omenn | Samir Hanash
  • Special Issue
  • - Volume 20
  • - Article ID 579363

Advancement of Biomarker Discovery and Validation through the HUPO Plasma Proteome Project

Gilbert S. Omenn
  • Special Issue
  • - Volume 20
  • - Article ID 913436

The Use of Laser Capture Microscopy in Proteomics Research – A Review

George M. Kunz | Daniel W. Chan
Download Special Issue
Disease Markers
Journal metrics
Acceptance rate35%
Submission to final decision91 days
Acceptance to publication48 days
CiteScore2.640
Impact Factor2.761
APC$1950
Submit
Author guidelines Editorial board Databases and indexing
Sign up for content alertsSign up

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.